Skip to main content
Clinical Trials/ACTRN12614000545662
ACTRN12614000545662
Completed
Phase 4

Effect of ultra-low-dose naloxone added to fentanyl- lidocaine for peribulbar anesthesia on the duration of post-operative analgesia in Patients undergoing cataract surgery.

Hoda Alsaid Ahmed Ezz0 sites60 target enrollmentMay 21, 2014

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Cataract surgery
Sponsor
Hoda Alsaid Ahmed Ezz
Enrollment
60
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 21, 2014
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Hoda Alsaid Ahmed Ezz

Eligibility Criteria

Inclusion Criteria

  • adult patients of both sexes, ASA I and II scheduled for open globe cataract surgery in the Ophthalmology Department Tanta University Hospital were included.

Exclusion Criteria

  • Exclusion criteria included clotting abnormalities and patients on anticoagulant therapy, impaired mental status, patients with communication difficulties, uncontrolled movements or tremors e.g. Parkinsonism, inability to lie flat, one eyed patients, uncontrolled glaucoma, recent surgical procedure on the same eye, high myopia, with axial length more than or equal 26 mm as detected by ultrasonography, and allergy to hyaluronidase or local anesthetics.

Outcomes

Primary Outcomes

Not specified

Similar Trials